IFP Advisors’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $837K | Sell |
1,544
-1
| -0.1% | -$563 | 0.02% | 812 |
|
|
2026
Q1 | $916K | Sell |
1,545
-193
| -11% | -$96.1K | 0.02% | 727 |
|
|
2025
Q4 | $847K | Buy |
1,738
+184
| +12% | +$85.7K | 0.02% | 720 |
|
|
2025
Q3 | $651K | Sell |
1,554
-610
| -28% | -$205K | 0.02% | 762 |
|
|
2025
Q2 | $622K | Buy |
2,164
+425
| +24% | +$127K | 0.02% | 745 |
|
|
2025
Q1 | $536K | Buy |
1,739
+884
| +103% | +$303K | 0.02% | 744 |
|
|
2024
Q4 | $302K | Sell |
855
-194
| -18% | -$71.3K | 0.01% | 941 |
|
|
2024
Q3 | $376K | Buy |
1,049
+612
| +140% | +$207K | 0.01% | 804 |
|
|
2024
Q2 | $139K | Buy |
437
+33
| +8% | +$8.73K | 0.01% | 1216 |
|
|
2024
Q1 | $92.8K | Sell |
404
-132
| -25% | -$29.8K | ﹤0.01% | 1326 |
|
|
2023
Q4 | $118K | Buy |
536
+121
| +29% | +$27.9K | 0.01% | 1175 |
|
|
2023
Q3 | $93.7K | Sell |
415
-119
| -22% | -$27.4K | ﹤0.01% | 1281 |
|
|
2023
Q2 | $118K | Buy |
534
+310
| +138% | +$68.7K | ﹤0.01% | 1240 |
|
|
2023
Q1 | $24K | Sell |
224
-338
| -60% | -$83.3K | ﹤0.01% | 1937 |
|
|
2022
Q4 | $96K | Sell |
562
-173
| -24% | -$43.7K | ﹤0.01% | 1765 |
|
|
2022
Q3 | $108K | Buy |
735
+260
| +55% | +$58.1K | ﹤0.01% | 1806 |
|
|
2022
Q2 | $76K | Hold |
475
| – | – | ﹤0.01% | 1880 |
|
|
2022
Q1 | $76K | Buy |
475
+437
| +1,150% | +$83.3K | ﹤0.01% | 1880 |
|
|
2021
Q4 | $8K | Hold |
38
| – | – | ﹤0.01% | 2315 |
|
|
2021
Q3 | $7K | Hold |
38
| – | – | ﹤0.01% | 2443 |
|
|
2021
Q2 | $7K | Hold |
38
| – | – | ﹤0.01% | 2364 |
|
|
2021
Q1 | $7K | Hold |
38
| – | – | ﹤0.01% | 2294 |
|
|
2020
Q4 | $5K | Hold |
38
| – | – | ﹤0.01% | 2346 |
|
|
2020
Q3 | $4K | Buy |
38
+11
| +41% | +$1.21K | ﹤0.01% | 2292 |
|
|
2020
Q2 | $3K | Buy |
27
+18
| +200% | +$2.02K | ﹤0.01% | 2298 |
|
|
2020
Q1 | $1K | Hold |
9
| – | – | ﹤0.01% | 2629 |
|
|
2019
Q4 | $1K | Hold |
9
| – | – | ﹤0.01% | 2735 |
|
|
2019
Q3 | $1K | Buy |
+9
| New | +$725 | ﹤0.01% | 2941 |
|
|
2019
Q1 | – | Sell |
-120
| Closed | -$13K | – | 3407 |
|
|
2018
Q4 | $13K | Sell |
120
-77
| -39% | -$8.93K | ﹤0.01% | 2377 |
|
|
2018
Q3 | $25K | Hold |
197
| – | – | ﹤0.01% | 2344 |
|
|
2018
Q2 | $22K | Sell |
197
-78
| -28% | -$8.57K | ﹤0.01% | 2416 |
|
|
2018
Q1 | $41K | Hold |
275
| – | – | ﹤0.01% | 1938 |
|
|
2017
Q4 | $41K | Hold |
275
| – | – | ﹤0.01% | 1958 |
|
|
2017
Q3 | $32K | Sell |
275
-112
| -29% | -$14.3K | ﹤0.01% | 2302 |
|
|
2017
Q2 | $50K | Buy |
387
+152
| +65% | +$19K | ﹤0.01% | 1978 |
|
|
2017
Q1 | $32K | Hold |
235
| – | – | ﹤0.01% | 2201 |
|
|
2016
Q4 | $34K | Buy |
235
+10
| +4% | +$1.28K | ﹤0.01% | 2109 |
|
|
2016
Q3 | $27K | Sell |
225
-170
| -43% | -$20.4K | ﹤0.01% | 2220 |
|
|
2016
Q2 | $42K | Buy |
+395
| New | +$44.1K | ﹤0.01% | 1885 |
|
|
2016
Q1 | – | Sell |
-393
| Closed | -$62K | – | 3413 |
|
|
2015
Q4 | $62K | Buy |
+393
| New | +$57.2K | ﹤0.01% | 1475 |
|
Other funds holding UTHR
ACA
JT
IFP Advisors's UTHR Position: Q2 2026 in Review
IFP Advisors reduced its United Therapeutics (UTHR) stake by 0.06% in Q2 2026, selling an estimated $563 and leaving 1,544 shares worth $837K. The position accounts for 0.02% of the portfolio, ranked #812.
IFP Advisors first reported a position in UTHR in Q4 2015 and has held it in 40 quarters since. The position peaked at $916K in Q1 2026. 881 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- IFP Advisors held 1,544 shares of United Therapeutics worth $837K as of Q2 2026.
- IFP Advisors sold 1 United Therapeutics share in Q2 2026, an estimated $563.
- United Therapeutics made up 0.02% of IFP Advisors's portfolio in Q2 2026, its #812 holding.
- IFP Advisors first reported a position in United Therapeutics in Q4 2015 and has held it in 40 quarters since.
- IFP Advisors's United Therapeutics position peaked at $916K in Q1 2026.
- 881 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.